Stocktoria
Black Diamond Therapeutics, Inc. BDTX
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2020-01-30
Black Diamond Therapeutics, Inc. institutional holders (13F)
| Investor | Shares | Value |
|---|---|---|
| BlackRock Finance, Inc. | 3,217,128 | $15.0M |
| RENAISSANCE TECHNOLOGIES LLC | 1,643,747 | $3.5M |
| CITADEL ADVISORS LLC | 604,552 | $1.3M |
| D. E. Shaw & Co., Inc. | 363,921 | $775,152 |
| MILLENNIUM MANAGEMENT LLC | 134,979 | $287,505 |
| Point72 Asset Management, L.P. | 100,985 | $215,098 |
| TWO SIGMA INVESTMENTS, LP | 43,300 | $92,229 |
Source: SEC EDGAR filings · CIK 0001701541 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.